219 related articles for article (PubMed ID: 16891049)
21. An integrative test strategy for cancer hazard identification.
Luijten M; Olthof ED; Hakkert BC; Rorije E; van der Laan JW; Woutersen RA; van Benthem J
Crit Rev Toxicol; 2016 Aug; 46(7):615-39. PubMed ID: 27142259
[TBL] [Abstract][Full Text] [Related]
22. A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity?
Petkov PI; Patlewicz G; Schultz TW; Honma M; Todorov M; Kotov S; Dimitrov SD; Donner EM; Mekenyan OG
Regul Toxicol Pharmacol; 2015 Jun; 72(1):17-25. PubMed ID: 25792138
[TBL] [Abstract][Full Text] [Related]
23. International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances.
Jacobs MN; Colacci A; Louekari K; Luijten M; Hakkert BC; Paparella M; Vasseur P
ALTEX; 2016; 33(4):359-392. PubMed ID: 27120445
[TBL] [Abstract][Full Text] [Related]
24. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
Osimitz TG; Droege W; Boobis AR; Lake BG
Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
[TBL] [Abstract][Full Text] [Related]
26. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
[TBL] [Abstract][Full Text] [Related]
27. A perspective on current and future uses of alternative models for carcinogenicity testing.
Goodman JI
Toxicol Pathol; 2001; 29 Suppl():173-6. PubMed ID: 11695554
[TBL] [Abstract][Full Text] [Related]
28. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis.
Bolt HM; Degen GH
Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528
[TBL] [Abstract][Full Text] [Related]
29. Opportunities to integrate new approaches in genetic toxicology: an ILSI-HESI workshop report.
Zeiger E; Gollapudi B; Aardema MJ; Auerbach S; Boverhof D; Custer L; Dedon P; Honma M; Ishida S; Kasinski AL; Kim JH; Manjanatha MG; Marlowe J; Pfuhler S; Pogribny I; Slikker W; Stankowski LF; Tanir JY; Tice R; van Benthem J; White P; Witt KL; Thybaud V
Environ Mol Mutagen; 2015 Apr; 56(3):277-85. PubMed ID: 25482136
[TBL] [Abstract][Full Text] [Related]
30. The syrian hamster embryo (SHE) cell transformation assay: review of the methods and results.
Mauthe RJ; Gibson DP; Bunch RT; Custer L
Toxicol Pathol; 2001; 29 Suppl():138-46. PubMed ID: 11695550
[TBL] [Abstract][Full Text] [Related]
31. Application of the margin of exposure (MoE) approach to substances in food that are genotoxic and carcinogenic: EXAMPLE 12: Sudan I (CAS No. 842-07-9).
Coulet M; Leblanc JC; Setzer RW
Food Chem Toxicol; 2010 Jan; 48 Suppl 1():S106-11. PubMed ID: 20113850
[TBL] [Abstract][Full Text] [Related]
32. Neonatal mouse model: review of methods and results.
McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
[TBL] [Abstract][Full Text] [Related]
33. Application of the margin of exposure (MOE) approach to substances in food that are genotoxic and carcinogenic. Example: leucomalachite green.
Renwick A; Leblanc JC; Setzer RW
Food Chem Toxicol; 2010 Jan; 48 Suppl 1():S75-80. PubMed ID: 19786059
[TBL] [Abstract][Full Text] [Related]
34. Quantitative assessment of cumulative carcinogenic risk for multiple genotoxic impurities in a new drug substance.
Bercu JP; Hoffman WP; Lee C; Ness DK
Regul Toxicol Pharmacol; 2008 Aug; 51(3):270-7. PubMed ID: 18550240
[TBL] [Abstract][Full Text] [Related]
35. Regulatory forum opinion piece*: supporting the need for international harmonization of safety assessments for food flavoring substances.
Konishi Y; Hayashi SM; Fukushima S
Toxicol Pathol; 2014 Aug; 42(6):949-53. PubMed ID: 23881932
[TBL] [Abstract][Full Text] [Related]
36. Application of the margin-of-exposure (MoE) approach to substances in food that are genotoxic and carcinogenic e.g.: benzo[a]pyrene and polycyclic aromatic hydrocarbons.
Benford D; Dinovi M; Setzer RW
Food Chem Toxicol; 2010 Jan; 48 Suppl 1():S42-8. PubMed ID: 19818825
[TBL] [Abstract][Full Text] [Related]
37. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
Eastmond DA; Hartwig A; Anderson D; Anwar WA; Cimino MC; Dobrev I; Douglas GR; Nohmi T; Phillips DH; Vickers C
Mutagenesis; 2009 Jul; 24(4):341-9. PubMed ID: 19535363
[TBL] [Abstract][Full Text] [Related]
38. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
McGregor D
Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
[TBL] [Abstract][Full Text] [Related]
39. Detection of genotoxic and non-genotoxic carcinogens in Xpc(-/-)p53(+/-) mice.
Melis JP; Speksnijder EN; Kuiper RV; Salvatori DC; Schaap MM; Maas S; Robinson J; Verhoef A; van Benthem J; Luijten M; van Steeg H
Toxicol Appl Pharmacol; 2013 Jan; 266(2):289-97. PubMed ID: 23153559
[TBL] [Abstract][Full Text] [Related]
40. Hazard identification, classification, and risk assessment of carcinogens: too much or too little? - Report of an ECETOC workshop.
Felter SP; Boobis AR; Botham PA; Brousse A; Greim H; Hollnagel HM; Sauer UG
Crit Rev Toxicol; 2020 Jan; 50(1):72-95. PubMed ID: 32133908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
